The largest database of trusted experimental protocols

13 protocols using balb c mice

1

Biodistribution of Cu-AAV in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiments were conducted under an animal use protocol approved by the University of California, Davis, Institutional Animal Care and Use Committee (IACUC) or Stanford University, Administrative Panel on Laboratory Animal Care (APLAC). For PET studies and biodistribution, 64Cu-labeled AAVs were evaluated in wild-type 7–9-week-old female C57BL/6 and 9 week-old-female BALB/c mice (The Jackson laboratory, Bar Harbor, ME). For neuraminidase-treated BALB/c mice, neuraminidase (0.12 units/20 μL, Sigma-Aldrich, #N7885) was intranasally administered 3 h before the injection of 64Cu-AAVs. The classical pharmacokinetics and biodistribution studies with qPCR were conducted with wild-type 5–6 week-old female C57BL/6 mice (Charles River).
+ Open protocol
+ Expand
2

RSV Nucleoprotein Antibody Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
RSV recombinant nucleoprotein (rNP) (50 µg/100 μL) was mixed with an equal volume of Freund’s complete adjuvant (Sigma-Aldrich, St. Louis, MO, USA) and injected intraperitoneally into six-week-old female BALB/c mice, which were obtained from Orient (Seongnam, Gyeonggi, Korea). Mice were biweekly boosted with RSV rNP (25 μg/100 μL) mixed with an equal volume of Freund’s incomplete adjuvant. The cell fusion technique and indirect ELISA were performed according to previously established protocols [34 (link)]. The isotyping of mAbs was performed with Immuno-Type™ mouse mAb isotyping kit (Sigma-Aldrich) following the manufacturer’s instructions.
+ Open protocol
+ Expand
3

BALB/c Mice Intranasal Inoculation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four-week-old female BALB/c mice (Laboratory Animal Centre of Wuhan Institute of Virology, CAS) were anaesthetized with 250 mg/kg of Averdin (Sigma-Aldrich, St. Louis, USA) before animals were inoculated intranasally with 105 TCID50 of WIV2, WIV3, WIV7 or the DMEM as mock control. Clinical symptoms and body weight were monitored every day up to 21 days. Virus replication and pathogenesis were determined on tissues collected from mice at 1, 3, 5, 7, 10, 14 and 21 days post-infection (dpi). Serum samples were separated from the whole blood by clotting at 37 °C for 1 h and centrifugation at 3,000×g for 10 min.
+ Open protocol
+ Expand
4

Preclinical Chemotherapy Evaluation in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
For chemotherapy testing, Balb/c mice under isoflurane anesthesia (Sigma-Aldrich Corp.) were challenged with 2 × 105 trypan blue negative P388/S or P388/ADR cells subcutaneously (s.c.) in a volume of 200 μl. Untreated mice were kept in order to determine the lethality of the challenge without chemotherapeutic intervention. Long-term survival was defined as challenged mice that survived the duration of the observation period.
+ Open protocol
+ Expand
5

Propagation and Titration of MCMV

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Smith strain of wild type MCMV, which had been passaged in mouse embryonic fibroblasts (MEFs), was provided by Dr. Y. Minamishima (Miyazaki, Japan, [21 (link)]). MEFs were prepared from 12.5-day-old embryos of BALB/c mice (SLC Japan), and were grown in Dulbecco's modified Eagle's essential medium (DMEM; Sigma-Aldrich, Merck, #D5796, Darmstadt, German) containing penicillin (100 units /ml), streptomycin (50 μg/ml), and 10% fetal bovine serum (FBS; Gibco, Thermo Fisher Scientific, #26140079, Waltham, MA). The viral titer was determined by a plaque assay in MEF monolayers as described previously [61 (link)].
+ Open protocol
+ Expand
6

Immunization Protocol for BALB/c Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten female BALB/c mice (16–18 g) (Theodor Bilhariz Research Institute, Giza, Egypt) were immunized with 25 µg polypeptide emulsified with Complete Freund’s adjuvant (Sigma-Aldrich, St. Louis, MI, USA) subcutaneously. The mice were boosted after 21 days with 12.5 µg polypeptide emulsified with InComplete Freund’s adjuvant (Sigma-Aldrich, St. Louis, MI, USA) via the same route then boosted one more time with 12.5 µg polypeptide in PBS intraperitoneally after 2 additional weeks. On day 45, mice were sacrificed, blood was collected by exsanguination of the posterior vena cava, the serum was separated and stored at −20 °C. Mice injected with pyrogen-free saline instead of the polypeptide were used as a negative control.
+ Open protocol
+ Expand
7

Aggregated MSC1 and MSC1-HI Cell Transplantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prior to transplantation, MSC1 and MSC1-HI cells were cultured and aggregated in non-tissue culture plates using Ham’s F10 media containing supplements for 48 h at 37 °C [17 (link)]. Six million MSC1 or MSC1-HI cells (estimated using a DNA assay [54 (link)]) were transplanted under the left renal subcapsular space of male BALB/c mice rendered diabetic by streptozotocin (270–275 mg/kg of body weight, Sigma Chemical Co., Burlington, MA, USA) injected intraperitoneally 7 days before transplantation, as previously described in Kaur et al., 2014 [16 (link)].
+ Open protocol
+ Expand
8

Glucosamine Alleviates Atopic Dermatitis in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study was carried out in female BALB/c mice (Orient Bio Inc., Seongnam, Korea) aged 8 weeks with AD induced by ovalbumin (OVA; Sigma-Aldrich Korea, Yongin, Korea). Twenty-five BALB/c mice were divided into five groups of five mice: control group without induction of AD (group A), AD group with null treatment by phosphate-buffered saline (PBS) (group B), and AD groups treated with 10 mg, 20 mg, and 40 mg of GlcN (Sigma-Aldrich Korea) administration (groups C, D, and E, respectively). For the AD induction groups (groups B~E), 1.5 ml of OVA and 3 ml of aluminum hydroxide gel (Thermo Fisher Scientific, Waltham, MA, USA) were mixed, and 150 µl of the mixture was intraperitoneally injected into the mice three times a week for three weeks. After a week of OVA injection, mice were epicutaneously sensitized with OVA patches. The patches were made by dripping 50 µl of OVA (1 mg/ml) in a gauze (1×1 cm) which was placed on the back skin three times per week for two weeks. Group A was injected with PBS instead of OVA. This experiment was conducted in specific-pathogen-free environment and the mice received an OVA-free diet. This study was reviewed and approved by the Institutional Animal Care and Use Committee of Inha University (INHA 181120-601).
+ Open protocol
+ Expand
9

Diabetic Foot Ulcer Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
We established the mice model of DFU according to the previous study of Li [22 (link)]. In general, male BALB/c mice (Shanghai Laboratory Animal Center of Chinese Academy of Sciences, China) with 5 weeks age and 19.39 ± 1.56 g weight were treated with 0.45% streptozotocin (Sigma, USA, 45 mg/kg) and feed with high-fat diet. We choosed these mice with the blood glucose level at 16.7 mmol/L to establish DFU model. There were 62 mice with DM. Then, we used the sterile punch to make wounds. Finally, exosomes derived from mmu_circ_0001052-modified ADSCs (exosomes + mmu_circ_0001052 group) or exosomes from vector-modified ADSCs (exosome + vector group) were subcutaneously injected. 25 μL of exosomes (200 μg in 100 μL PBS) were subcutaneously injected at 4 sites around the wound. The control group was not treated with exosomes. Wound tissues were collected at 3, 7 and 14 days after wounding. This study, following the Nation Institutes of Health Guide for the Laboratory Animals Care and Use, was carried out with the approval of hospital ethics committee, and Ethical approval No.:Med-Eth-Re [2021] 192.
+ Open protocol
+ Expand
10

Immunization and Antibody Titration Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified rPDHA and rPDHB proteins, and M. gallisepticum whole cells (inactivated with 0.4% formalin for 16 h at 37°C) were emulsified with an equal volume of Freund’s complete adjuvant (Sigma) and used to immunize 6-week-old female BALB/c mice (SLAC, Shanghai, China) via multipoint subcutaneous injection respectively (100 μg purified protein or 1010 colony forming units [CFUs] M. gallisepticum whole cells per mouse). After the first immunization, two boosters were given at 2-week intervals. Two non-immunized mice were used as negative controls. Tail vein blood from immunized and non-immunized mice was collected and the titres of polyclonal antisera measured by indirect enzyme-linked immunosorbent assay (iELISA) as previously described [22 (link)], with 96-well plates coated with coating buffer (16 mM Na2CO3, 34 mM NaHCO3, pH 9.6) containing purified protein (0.5 μg per well) or M. gallisepticum total protein prepared by sonic disruption of M. gallisepticum bacteria (0.5 μg per well) overnight at 4°C. When titres significantly increased, blood samples were collected from the infraorbital sinuses of mice and serum samples were separated and stored at −20°C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!